Johns Hopkins Researchers Identify Colon Cancer Toxin Receptor

Scientists discover that the claudin-4 protein serves as the docking point for a common gut bacterium toxin.

Updated on Oct. 31, 2026 in Cancer

Abstract macro view of cellular protein structures interacting with molecular particles, representing biological research. — Johns Hopkins researchers identified the claudin-4 protein as the essential receptor for a toxin linked to colon tumor formation, offering a potential target for new clinical interventions. AI Illustration. Upload story photo >

Live Poll

Should more research funding be directed toward identifying environmental triggers for chronic diseases like cancer?

Researchers at Johns Hopkins have identified claudin-4 as the essential receptor for the Bacteroides fragilis toxin, which promotes tumor formation in the colon. The study, conducted with collaborators, also successfully tested a molecular decoy to block the toxin in mice.

Why it matters

Identifying the specific docking mechanism for this toxin provides a critical target for developing new interventions to prevent toxin-related colon damage. This discovery marks a significant step toward neutralizing the damage caused by the bacterium found in the gut.

Bacteroides fragilis is a common gut bacterium identified in 20% of healthy individuals. Researchers confirmed through structural analysis that the protein claudin-4 and the bacterial toxin BFT form a tightly bound complex.

The players

Johns Hopkins

This primary research institution led the study to identify the receptor for the toxin produced by Bacteroides fragilis.

Harvard Medical School

This collaborating research institution contributed to the scientific investigation of colon tumor formation.

Molecular Biology Institute of Barcelona

This institute provided structural analysis to confirm the molecular complex between the toxin and the cellular receptor.

The details

Using CRISPR technology to systematically disable genes in colon epithelial cells, the team isolated the claudin-4 protein as the required attachment point for the BFT toxin. They subsequently developed a soluble decoy protein to lure the toxin away from healthy cells.

A 2009 study first linked the BFT toxin to colon tumor formation.
The findings were published and announced on October 31, 2026.

The Big Picture

This discovery builds directly upon the 2009 study linking BFT to colon tumor formation by finally identifying the specific docking mechanism involved. It shifts the research trajectory from identifying the link between the toxin and cancer to actively blocking the interaction.

This development offers a potential future pathway for preventing colon damage in individuals carrying the Bacteroides fragilis bacterium. While currently tested in mice, the research aims to lead to new biologics that could eventually impact human treatment options.

The takeaway

This discovery provides a concrete target for future medical interventions against toxin-induced colon damage. Scientists are now exploring how to refine these decoy proteins into safe therapeutic tools for human use.